Health-related quality-of-life (HRQoL) reporting by randomized cancer trials (RCT): Pitfalls for interpretation.
作者： L. Testa , C. C. Barbosa , A. C. Chaves , P. M. Hoff , R. P. Riechelmann
DOI: 10.1200/JCO.2011.29.15_SUPPL.6102
关键词: Intensive care medicine 、 Pediatrics 、 Cancer 、 Alternative medicine 、 Patient benefit 、 Medicine 、 Health related quality of life 、 Overall survival 、 Quality of life (healthcare) 、 Randomized controlled trial
摘要: 6102 Background: Overall survival and HRQoL are well-recognized direct measures of patient benefit. While is an easily defined endpoint, the definition measure quality life le...
sci-hub.st 参考文章(0)